Co-Delivery of 5-Fluorouracil and Paclitaxel in Mitochondria-Targeted KLA-Modified Liposomes to Improve Triple-Negative Breast Cancer Treatment
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Co-Delivery of 5-Fluorouracil and Paclitaxel in Mitochondria-Targeted KLA-Modified Liposomes to Improve Triple-Negative Breast Cancer Treatment
Authors
Keywords
-
Journal
Pharmaceuticals
Volume 15, Issue 7, Pages 881
Publisher
MDPI AG
Online
2022-07-18
DOI
10.3390/ph15070881
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mitochondrion-specific dendritic lipopeptide liposomes for targeted sub-cellular delivery
- (2021) Lei Jiang et al. Nature Communications
- Novel nanomedicines to overcome cancer multidrug resistance
- (2021) Zhenwei Su et al. DRUG RESISTANCE UPDATES
- Synergistic Growth Inhibition of HT-29 Colon and MCF-7 Breast Cancer Cells with Simultaneous and Sequential Combinations of Antineoplastics and CNS Drugs
- (2021) Diana Duarte et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting Thymidylate Synthase Enhances the Chemosensitivity of Triple-Negative Breast Cancer Towards 5-FU-Based Combinatorial Therapy
- (2021) Nair Hariprasad Haritha et al. Frontiers in Oncology
- Bioactive nanotherapeutic trends to combat triple negative breast cancer
- (2021) Pallabita Chowdhury et al. Bioactive Materials
- Triple-Negative Breast Cancer: A Review of Conventional and Advanced Therapeutic Strategies
- (2020) Mauricio A. Medina et al. International Journal of Environmental Research and Public Health
- Mesoporous Silica Nanoparticles for Targeting Subcellular Organelles
- (2020) Miguel Gisbert-Garzarán et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Current Progresses and Challenges of Immunotherapy in Triple-Negative Breast Cancer
- (2020) Karan Mediratta et al. Cancers
- Traditional Chinese medicine-combination therapies utilizing nanotechnology-based targeted delivery systems: a new strategy for antitumor treatment
- (2019) Zhe Ma et al. International Journal of Nanomedicine
- Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Trastuzumab Followed by 5-Fluorouracil/Epirubicin/Cyclophosphamide for HER2-positive Operable Breast Cancer: A Multicenter Phase II Trial
- (2019) SHINYA TOKUNAGA et al. ANTICANCER RESEARCH
- Recent advances in nanotheranostics for triple negative breast cancer treatment
- (2019) Vikram Thakur et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Macrophage-Derived Extracellular Vesicles as Drug Delivery Systems for Triple Negative Breast Cancer (TNBC) Therapy
- (2019) Matthew J. Haney et al. Journal of Neuroimmune Pharmacology
- Recent Progress in Mitochondria-Targeted Drug and Drug-Free Agents for Cancer Therapy
- (2019) M.T. Jeena et al. Cancers
- Tumor targeting via EPR: Strategies to enhance patient responses
- (2018) Susanne K. Golombek et al. ADVANCED DRUG DELIVERY REVIEWS
- Surface Functionalization and Targeting Strategies of Liposomes in Solid Tumor Therapy: A Review
- (2018) Muhammad Riaz et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Arginine, glycine, aspartic acid peptide-modified paclitaxel and curcumin co-loaded liposome for the treatment of lung cancer: in vitro/vivo evaluation
- (2018) Kanqiu Jiang et al. International Journal of Nanomedicine
- Mitochondria-targeted delivery of doxorubicin to enhance antitumor activity with HER-2 peptide-mediated multifunctional pH-sensitive DQAsomes
- (2018) Menghao Shi et al. International Journal of Nanomedicine
- Paclitaxel, oxaliplatin, 5-fluorouracil and leucovorin combination chemotherapy in patients with recurrent or metastatic gastric cancer
- (2018) Yan-qin Lan et al. TUMORI
- Paclitaxel, oxaliplatin, 5-fluorouracil and leucovorin combination chemotherapy in patients with recurrent or metastatic gastric cancer
- (2018) Yan-qin Lan et al. TUMORI JOURNAL
- Basic principles of drug delivery systems – the case of paclitaxel
- (2018) S. Ezrahi et al. ADVANCES IN COLLOID AND INTERFACE SCIENCE
- Paclitaxel, 5-fluorouracil, and leucovorin combination chemotherapy as first-line treatment in patients with advanced gastric cancer
- (2018) Wan-Cai Que et al. ANTI-CANCER DRUGS
- Enhanced Anticancer Activity of 5’-DFUR-PCL-MPEG Polymeric Prodrug Micelles Encapsulating Chemotherapeutic Drugs
- (2018) Alicia Sawdon et al. Nanomaterials
- Enhanced anticancer efficacy of paclitaxel through multistage tumor-targeting liposomes modified with RGD and KLA peptides
- (2017) Jiawei Sun et al. International Journal of Nanomedicine
- Liposome-based drug co-delivery systems in cancer cells
- (2017) Sepideh Zununi Vahed et al. Materials Science & Engineering C-Materials for Biological Applications
- Complete response in a patient with liver metastases from breast cancer employing hepatic arterial infusion 5-fluorouracil based chemotherapy plus systemic nab-paclitaxel
- (2017) Girolamo Ranieri et al. Oncotarget
- Tumor targeting strategies for chitosan-based nanoparticles
- (2016) Xingzhen Zhang et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Novel targets for paclitaxel nano formulations: Hopes and hypes in triple negative breast cancer
- (2016) Anita K. Bakrania et al. PHARMACOLOGICAL RESEARCH
- Triple-negative breast cancer: is there a treatment on the horizon?
- (2016) Hui Yao et al. Oncotarget
- Overcoming drug-resistant lung cancer by paclitaxel loaded dual-functional liposomes with mitochondria targeting and pH-response
- (2015) Lei Jiang et al. BIOMATERIALS
- Nanocarrier-mediated co-delivery of chemotherapeutic drugs and gene agents for cancer treatment
- (2015) Lin Kang et al. Acta Pharmaceutica Sinica B
- Multistage pH-Responsive Liposomes for Mitochondrial-Targeted Anticancer Drug Delivery
- (2012) Ran Mo et al. ADVANCED MATERIALS
- Gene transfer efficacies of serum-resistant amino acids-based cationic lipids: Dependence on headgroup, lipoplex stability and cellular uptake
- (2011) Li Li et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma
- (2011) L. Agemy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Particle Shape: A New Design Parameter for Passive Targeting In Splenotropic Drug Delivery
- (2010) Padma V. Devarajan et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Demethylating agent 5-aza-2-deoxycytidine enhances susceptibility of breast cancer cells to anticancer agents
- (2010) Sameer Mirza et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Targeting mitochondria for cancer therapy
- (2010) Simone Fulda et al. NATURE REVIEWS DRUG DISCOVERY
- Effect of surface charge of magnetite nanoparticles on their internalization into breast cancer and umbilical vein endothelial cells
- (2009) Tetsuya Osaka et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Subcellular targeting strategies for drug design and delivery
- (2009) Lawrence Rajendran et al. NATURE REVIEWS DRUG DISCOVERY
- A phase II study of paclitaxel and capecitabine as a first-line combination chemotherapy for advanced gastric cancer
- (2008) H J Kang et al. BRITISH JOURNAL OF CANCER
- From delocalized lipophilic cations to hypoxia: Blocking tumor cell mitochondrial function leads to therapeutic gain with glycolytic inhibitors
- (2008) Metin Kurtoglu et al. MOLECULAR NUTRITION & FOOD RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started